Matches in SemOpenAlex for { <https://semopenalex.org/work/W3030625209> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W3030625209 endingPage "214" @default.
- W3030625209 startingPage "212" @default.
- W3030625209 abstract "ObjectiveTo explore the effects of matrine on apoptosis and nuclear factor(NF)-κBp65 activity of HL-60 cells induced by pirarubicin(THP).MethodsEffects of the apoptosis: the HL-60 cells in blank control group were cultured 14 hours with RPMI 1640; groups of different concentration drugs: matrine: 0.1 μmol/L, 1.0 μmol/L, 10.0 μmol/L and THP: 1.0 μmol/L, 10.0 μmol/L, 100.0 μmol/L.The apoptosis of HL-60 cells were tested by fluorescence double colour painting and flow cytometry(FCM). The NF-κBp65 activity of HL-60 cells were determined by FCM.ResultsThe rates of apoptosis of HL-60 cells were (7.14±2.95)%, (12.34±2.55)%, (19.3±2.31)% and (31.78±4.31)%, (47.25±5.27)%, (56.49±1.59)% in matrine 0.1 μmol/L, 1.0 μmol/L, 10.0 μmol/L and THP 1.0 μmol/L, 10.0 μmol/L, 100.0 μmol/L groups, compared to blank control group(6.46±1.45)%, there were significant difference (F=257.72, 677.19; all P<0.001); (70.17±5.68)% in matrine 0.1 μmol/L + THP 1.0 μmol/L group[vs the THP 1.0 μmol/L group (31.78±4.31)%, (t=38.94, P<0.001)]. The rates of NF-κBp65 activity of HL-60 cells in matrine 0.1 μmol/L, 1.0 μmol/L, 10.0 μmol/L and THP 1.0 μmol/L, 10.0 μmol/L, 100.0 μmol/L groups were(8.34±1.52)%, (7.11±1.29)%, (4.78±0.31)% and (16.21±1.20)%, (23.98±3.21)%, (32.44±2.89)%, with the control group( 8.44±2.20)%, there were significant difference(F=65.35, P<0.001; F=674.11, P<0.001); (12.01±2.27)% in matrine 0.1 μmol/L + THP 1.0 μmol/L group [with (16.21±1.20)% of THP 1.0 μmol/L group(t=21.42, P<0.001)].ConclusionsThe apoptosis of HL-60 cell is induced by matrine and pirarubicin in a dose-dependent manner.NF-κBp65 activity of HL-60 cell is inhibited by matrine and increased by pirarubicin in a dose-dependent manner.Matrine can enhannce the effect of induction by pirarubicin of apoptosis of HL-60 cell, and decrease activity of NF-κBp65 by pirarubicin.Key words: Matrine; Pirarubicin; Drug combination; Apoptosis; Nuclear factor-κBp65 activity" @default.
- W3030625209 created "2020-06-05" @default.
- W3030625209 creator A5048288156 @default.
- W3030625209 date "2014-02-05" @default.
- W3030625209 modified "2023-09-23" @default.
- W3030625209 title "Effects of matrine on apoptosis and nuclear factor kappaBp65 activity of HL-60 cells induced by pirarubicin" @default.
- W3030625209 doi "https://doi.org/10.3760/cma.j.issn.2095-428x.2014.03.014" @default.
- W3030625209 hasPublicationYear "2014" @default.
- W3030625209 type Work @default.
- W3030625209 sameAs 3030625209 @default.
- W3030625209 citedByCount "0" @default.
- W3030625209 crossrefType "journal-article" @default.
- W3030625209 hasAuthorship W3030625209A5048288156 @default.
- W3030625209 hasConcept C124815738 @default.
- W3030625209 hasConcept C126322002 @default.
- W3030625209 hasConcept C153911025 @default.
- W3030625209 hasConcept C185592680 @default.
- W3030625209 hasConcept C190283241 @default.
- W3030625209 hasConcept C2776085618 @default.
- W3030625209 hasConcept C2776545273 @default.
- W3030625209 hasConcept C2776694085 @default.
- W3030625209 hasConcept C43617362 @default.
- W3030625209 hasConcept C53009064 @default.
- W3030625209 hasConcept C553184892 @default.
- W3030625209 hasConcept C55493867 @default.
- W3030625209 hasConcept C71924100 @default.
- W3030625209 hasConcept C86803240 @default.
- W3030625209 hasConceptScore W3030625209C124815738 @default.
- W3030625209 hasConceptScore W3030625209C126322002 @default.
- W3030625209 hasConceptScore W3030625209C153911025 @default.
- W3030625209 hasConceptScore W3030625209C185592680 @default.
- W3030625209 hasConceptScore W3030625209C190283241 @default.
- W3030625209 hasConceptScore W3030625209C2776085618 @default.
- W3030625209 hasConceptScore W3030625209C2776545273 @default.
- W3030625209 hasConceptScore W3030625209C2776694085 @default.
- W3030625209 hasConceptScore W3030625209C43617362 @default.
- W3030625209 hasConceptScore W3030625209C53009064 @default.
- W3030625209 hasConceptScore W3030625209C553184892 @default.
- W3030625209 hasConceptScore W3030625209C55493867 @default.
- W3030625209 hasConceptScore W3030625209C71924100 @default.
- W3030625209 hasConceptScore W3030625209C86803240 @default.
- W3030625209 hasIssue "3" @default.
- W3030625209 hasLocation W30306252091 @default.
- W3030625209 hasOpenAccess W3030625209 @default.
- W3030625209 hasPrimaryLocation W30306252091 @default.
- W3030625209 hasRelatedWork W227558992 @default.
- W3030625209 hasRelatedWork W2365487874 @default.
- W3030625209 hasRelatedWork W2366978942 @default.
- W3030625209 hasRelatedWork W2382208773 @default.
- W3030625209 hasRelatedWork W2386604242 @default.
- W3030625209 hasRelatedWork W2388672225 @default.
- W3030625209 hasRelatedWork W2424702816 @default.
- W3030625209 hasRelatedWork W2438057350 @default.
- W3030625209 hasRelatedWork W2580243208 @default.
- W3030625209 hasRelatedWork W3029284436 @default.
- W3030625209 hasRelatedWork W3029339808 @default.
- W3030625209 hasRelatedWork W3029814223 @default.
- W3030625209 hasRelatedWork W3029836215 @default.
- W3030625209 hasRelatedWork W3030038589 @default.
- W3030625209 hasRelatedWork W3030912715 @default.
- W3030625209 hasRelatedWork W3031369225 @default.
- W3030625209 hasRelatedWork W3031599166 @default.
- W3030625209 hasRelatedWork W3032673438 @default.
- W3030625209 hasRelatedWork W3151535737 @default.
- W3030625209 hasRelatedWork W3030292125 @default.
- W3030625209 hasVolume "29" @default.
- W3030625209 isParatext "false" @default.
- W3030625209 isRetracted "false" @default.
- W3030625209 magId "3030625209" @default.
- W3030625209 workType "article" @default.